Author Details

Avdeev, S N

Issue Section Title File
Vol 79, No 3 (2004) Editorial Obliterating bronchiolytis induced by D-penicillamine in a female patient with systemic sclerosis
Vol 79, No 11 (2004) Editorial Exacerbated chronic obstructive pulmonary disease: current trends in diagnosis and treatment (review)
Vol 80, No 8 (2008) Editorial Is it possible to modify the course of chronic obstructive pulmonary disease with modern medication?
Vol 81, No 3 (2009) Editorial Thiotropium in bronchial asthma
Vol 83, No 3 (2011) Editorial Determination of clinical phenotypes of chronic obstructive pulmonary disease a new treatment approach
Vol 83, No 9 (2011) Editorial Pandemic flu in Russia: special features of a clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease
Vol 84, No 3 (2012) Editorial SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS
Vol 84, No 3 (2012) Editorial ORGANIZING PNEUMONIA: DIAGNOSIS AND TREATMENT
Vol 84, No 3 (2012) Editorial THE ROLE OF ENDOTHELIAL DYSFUNCTION AND ARTERIAL RIGIDITY IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Vol 84, No 4 (2012) Editorial CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Vol 84, No 12 (2012) Editorial Current guidelines for oxygen therapy in emergency care
Vol 85, No 3 (2013) Editorial First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
Vol 86, No 3 (2014) Editorial Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension
Vol 86, No 9 (2014) Editorial Clinical guidelines for the diagnosis and treatment of pulmonary hypertension
Vol 86, No 10 (2014) Editorial The 2013-2014 epidemic season. Hospital monitoring and antiviral therapy for influenza
Vol 87, No 9 (2015) Editorial Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
Vol 88, No 7 (2016) Editorial The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension PDF
(Rus)
Vol 88, No 8 (2016) Editorial Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas PDF
(Rus)
Vol 89, No 1 (2017) Editorial Idiopatic pulmonary fibrosis: A new paradigm PDF
(Rus)
Vol 89, No 9 (2017) Editorial A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out? PDF
(Rus)
Vol 90, No 3 (2018) Editorial Combination therapy is a new standard for treatment of pulmonary arterial hypertension PDF
(Rus)
Vol 90, No 12 (2018) Editorial Treatment of exacerbations of chronic obstructive pulmonary disease PDF
(Rus)
Vol 91, No 3 (2019) Editorial New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease PDF
(Rus)
Vol 91, No 3 (2019) Editorial Possibilities of ultrasound research of the diaphragm PDF
(Rus)
Vol 91, No 9 (2019) Editorial Risk stratification methods and their significance in pulmonary arterial hypertension PDF
(Rus)
Vol 91, No 10 (2019) Editorial Eosinophilic inflammation in chronic obstructive pulmonary disease PDF
(Rus)
Vol 91, No 12 (2019) Editorial Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma PDF
(Rus)
Vol 92, No 1 (2020) Editorial The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies